Harvard Bioscience (HBIO) EBITDA Margin Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -477.00 |
| Dec 31, 2025 | 15,824.00 |
| Sep 30, 2025 | -167.00 |
| Jun 30, 2025 | -25.00 |
| Mar 31, 2025 | -20,187.00 |
| Dec 31, 2024 | 1,009.00 |
| Sep 30, 2024 | 663.00 |
| Jun 30, 2024 | -652.00 |
| Mar 31, 2024 | -27.00 |
| Dec 31, 2023 | -1,278.00 |
| Sep 30, 2023 | -480.00 |
| Jun 30, 2023 | 1,602.00 |
| Mar 31, 2023 | 1,644.00 |
| Dec 31, 2022 | 1,427.00 |
| Sep 30, 2022 | -1,817.00 |
| Jun 30, 2022 | 519.00 |
| Mar 31, 2022 | -2,268.00 |
| Dec 31, 2021 | 939.00 |
| Sep 30, 2021 | 1,634.00 |
| Jun 30, 2021 | 990.00 |